title: Epidermal-type FABP is a predictive marker of clinical response to systemic treatment and ultraviolet therapy in psoriatic skin lesions.
authors.forename: Tomomi
authors.initials: T
authors.lastname: Miyake
authors.forename: Eisaku
authors.initials: E
authors.lastname: Ogawa
authors.forename: Asuka
authors.initials: A
authors.lastname: Mikoshiba
authors.forename: Aya
authors.initials: A
authors.lastname: Kobayashi
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Hosoe
authors.forename: Shoji
authors.initials: S
authors.lastname: Kashiwabara
authors.forename: Hisashi
authors.initials: H
authors.lastname: Uhara
authors.forename: Yuji
authors.initials: Y
authors.lastname: Owada
authors.forename: Ryuhei
authors.initials: R
authors.lastname: Okuyama
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D015415:Biomarkers / Q000378:metabolism; D050556:Fatty Acid-Binding Proteins / Q000097:blood / Q000378:metabolism*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000097:blood / Q000378:metabolism* / Q000532:radiotherapy / Q000628:therapy*; D012867:Skin / Q000378:metabolism; D014467:Ultraviolet Therapy
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers; C493412:FABP5 protein, human; D050556:Fatty Acid-Binding Proteins; D000069285:Infliximab; D000068879:Adalimumab